title: Blastic Plasmacytoid Dendritic Cell Neoplasm: How do You Distinguish It from Acute Myeloid Leukemia?
abstract: BPDCN is a recently elucidated clinicopathologic entity. This disease typically involves the skin, with 30% to 40% of patients showing an additional concurrent leukemic component. Although BPDCN often exhibits cytologic features akin to acute lymphoblastic leukemia, the main differential diagnostic challenge, in the skin and in the bone marrow, is distinction from AML, in particular AML with monocytic differentiation.
authors.affiliation: Division of Hematopathology, Mayo Clinic, 200 1st Street Southwest, Hilton Building 8th Floor, Rochester, MN 55902, USA. Electronic address: reichard.kaaren@mayo.edu.
authors.forename: Kaaren K
authors.initials: KK
authors.lastname: Reichard
keywords: Blastic; CD123; Cutis; Dendritic; Leukemia; Monocytic; Myeloid; Plasmacytoid